- Home
- ACIU vs WALD Comparison
ACIU vs WALD Comparison
Compare ACIU & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | WALD |
|---|---|---|
| Founded | 2003 | 1988 |
| Country | Switzerland | United Kingdom |
| Employees | 122 | 364 |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.9M | 187.3M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIU | WALD |
|---|---|---|
| Price | $2.14 | $1.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $10.00 | $2.00 |
| AVG Volume (30 Days) | 256.1K | ★ 638.5K |
| Earning Date | 05-12-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $706.75 | $9.89 |
| Revenue Next Year | $321.13 | $4.31 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $0.72 |
| 52 Week High | $4.00 | $3.22 |
Technical Indicators
Market Signals| Indicator | ACIU | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 36.96 | 54.02 |
| Support Level | $2.15 | $1.68 |
| Resistance Level | $2.66 | $1.95 |
| Average True Range (ATR) | 0.15 | 0.14 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 11.11 | 67.50 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.